Comments highlight need to advance bipartisan Equitable Community Access to Pharmacist Services Act (H.R. 1770/S. 2477); include pharmacists and pharmacies in CMS Innovation Center’s ongoing work to develop value-based care models; and support meaningful PBM reforms in Medicare and Medicaid to protect patient access to pharmacy services
NACDS’ all-levels and all-branches of government approach to PBM reform prioritizes the enactment, implementation, enforcement, and oversight of reforms.
Emphasizes that Congressional action needs to address the needs of Americans on Medicare and Medicaid and their pharmacies, and lauds Committee’s commitment
Oversight hearing “will examine pricing tactics deployed by [PBMs] to enrich themselves at the expense of patients across the country”.
Evidence of “pharmaceutical benefit manipulation” is piling up, as the push continues for comprehensive PBM reform at all levels and branches of government.
NACDS leadership welcomed NACDS-member retailers and suppliers to San Diego, CA, for the NACDS Total Store Expo — the third conference in the 2023 calendar of NACDS events celebrating the Association’s 90th Anniversary Year.
Sen. Crapo is leading a press conference in Twin Falls, ID, on addressing PBM practices that have grown increasingly complex and opaque in recent years at the expense of patients and taxpayers.
NACDS looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs.
A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance.
The FTC on Thursday voted, 3-0, “to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit managers (PBM) that no longer reflect current market realities.”
